4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0000950170-24-106441
Options or other derivatives
- President & CEO acquired 120,436 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hawryluk P. Kent President & CEO | 2024-09-12 | Grant or award · Stock Option (Right to Buy) | +120,436 | 120,436 | D | ||
Loading xslF345X05/ownership.xml…